Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Laboratorios Farmaceúticos Rovi Debt to Equity Ratio : 0.1698 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1698 |
| December 31, 2025 | 0.1834 |
| September 30, 2025 | 0.1988 |
| June 30, 2025 | 0.2294 |
| March 31, 2025 | 0.1837 |
| December 31, 2024 | 0.20 |
| September 30, 2024 | 0.2338 |
| June 30, 2024 | 0.2545 |
| March 31, 2024 | 0.1574 |
| December 31, 2023 | 0.1213 |
| September 30, 2023 | 0.1154 |
| June 30, 2023 | 0.1287 |
| March 31, 2023 | 0.1222 |
| December 31, 2022 | 0.1388 |
| September 30, 2022 | 0.1666 |
| June 30, 2022 | 0.1833 |
| March 31, 2022 | 0.1699 |
| December 31, 2021 | 0.1553 |
| September 30, 2021 | 0.1587 |
| June 30, 2021 | 0.1803 |
| March 31, 2021 | 0.183 |
| December 31, 2020 | 0.1992 |
| September 30, 2020 | 0.2027 |
| June 30, 2020 | 0.2139 |
| March 31, 2020 | 0.2279 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2631 |
| September 30, 2019 | 0.1413 |
| June 30, 2019 | 0.164 |
| March 31, 2019 | 0.1724 |
| December 31, 2018 | 0.1191 |
| September 30, 2018 | 0.1965 |
| June 30, 2018 | 0.1991 |
| March 31, 2018 | 0.2035 |
| December 31, 2017 | 0.2256 |
| September 30, 2017 | 0.2461 |
| June 30, 2017 | 0.1891 |
| March 31, 2017 | 0.27 |
| December 31, 2016 | 0.1843 |
| September 30, 2016 | 0.2102 |
| June 30, 2016 | 0.1457 |
| March 31, 2016 | 0.2382 |
| December 31, 2015 | 0.171 |
| September 30, 2015 | 0.2721 |
| June 30, 2015 | 0.22 |
| March 31, 2015 | 0.0487 |
| December 31, 2014 | 0.1297 |
| September 30, 2014 | 0.2414 |
| June 30, 2014 | 0.0059 |
| March 31, 2014 | 0.2016 |
| December 31, 2013 | 0.0084 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Almirall SA | -- |
| AstraZeneca PLC | 0.7166 |
| ANI Pharmaceuticals, Inc. | 1.092 |
| Corcept Therapeutics, Inc. | 0.0151 |
| Assertio Holdings, Inc. | 0.533 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.067B |
| Total Liabilities (Quarterly) | 276.05M |
| Shareholders Equity (Quarterly) | 776.47M |
| Current Ratio | 3.655 |
| Net Debt Paydown Yield | -0.08% |